nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.0198	0.0845	CbGeAlD
Risperidone—Iloperidone—SIGMAR1—amyotrophic lateral sclerosis	0.0114	1	CrCbGaD
Risperidone—HTR1B—cranial nerve—amyotrophic lateral sclerosis	0.0107	0.0458	CbGeAlD
Risperidone—HTR1D—cranial nerve—amyotrophic lateral sclerosis	0.0104	0.0443	CbGeAlD
Risperidone—HTR7—cranial nerve—amyotrophic lateral sclerosis	0.00827	0.0353	CbGeAlD
Risperidone—HTR7—pons—amyotrophic lateral sclerosis	0.00817	0.0349	CbGeAlD
Risperidone—DRD1—nerve—amyotrophic lateral sclerosis	0.00678	0.0289	CbGeAlD
Risperidone—Hypochromic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00676	0.00945	CcSEcCtD
Risperidone—Manic psychosis—Riluzole—amyotrophic lateral sclerosis	0.00663	0.00927	CcSEcCtD
Risperidone—Yawning—Riluzole—amyotrophic lateral sclerosis	0.00651	0.0091	CcSEcCtD
Risperidone—Dementia—Riluzole—amyotrophic lateral sclerosis	0.00639	0.00893	CcSEcCtD
Risperidone—Paranoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00616	0.00862	CcSEcCtD
Risperidone—Furunculosis—Riluzole—amyotrophic lateral sclerosis	0.00616	0.00862	CcSEcCtD
Risperidone—Cheilitis—Riluzole—amyotrophic lateral sclerosis	0.00616	0.00862	CcSEcCtD
Risperidone—Endophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.0055	0.00769	CcSEcCtD
Risperidone—HTR7—peripheral nervous system—amyotrophic lateral sclerosis	0.00544	0.0232	CbGeAlD
Risperidone—Cerebral ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00542	0.00758	CcSEcCtD
Risperidone—Tongue discolouration—Riluzole—amyotrophic lateral sclerosis	0.00542	0.00758	CcSEcCtD
Risperidone—Priapism—Riluzole—amyotrophic lateral sclerosis	0.00542	0.00758	CcSEcCtD
Risperidone—Furuncle—Riluzole—amyotrophic lateral sclerosis	0.00534	0.00747	CcSEcCtD
Risperidone—Muscle relaxant therapy—Riluzole—amyotrophic lateral sclerosis	0.00527	0.00736	CcSEcCtD
Risperidone—White blood cell count decreased—Riluzole—amyotrophic lateral sclerosis	0.00527	0.00736	CcSEcCtD
Risperidone—Bundle branch block—Riluzole—amyotrophic lateral sclerosis	0.00519	0.00726	CcSEcCtD
Risperidone—Faecal incontinence—Riluzole—amyotrophic lateral sclerosis	0.00519	0.00726	CcSEcCtD
Risperidone—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.00516	0.022	CbGeAlD
Risperidone—Lymphopenia—Riluzole—amyotrophic lateral sclerosis	0.00512	0.00716	CcSEcCtD
Risperidone—HTR2A—pons—amyotrophic lateral sclerosis	0.0051	0.0217	CbGeAlD
Risperidone—Renal pain—Riluzole—amyotrophic lateral sclerosis	0.00498	0.00697	CcSEcCtD
Risperidone—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.00498	0.00697	CcSEcCtD
Risperidone—Hypothermia—Riluzole—amyotrophic lateral sclerosis	0.00468	0.00654	CcSEcCtD
Risperidone—Body temperature decreased—Riluzole—amyotrophic lateral sclerosis	0.00468	0.00654	CcSEcCtD
Risperidone—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.00462	0.00646	CcSEcCtD
Risperidone—Cholecystitis—Riluzole—amyotrophic lateral sclerosis	0.00456	0.00638	CcSEcCtD
Risperidone—Gastric ulcer—Riluzole—amyotrophic lateral sclerosis	0.00451	0.0063	CcSEcCtD
Risperidone—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.00446	0.00623	CcSEcCtD
Risperidone—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.00441	0.00616	CcSEcCtD
Risperidone—Platelet count decreased—Riluzole—amyotrophic lateral sclerosis	0.00441	0.00616	CcSEcCtD
Risperidone—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.00436	0.00609	CcSEcCtD
Risperidone—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.00436	0.00609	CcSEcCtD
Risperidone—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.00435	0.0185	CbGeAlD
Risperidone—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.00431	0.00602	CcSEcCtD
Risperidone—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.00426	0.00596	CcSEcCtD
Risperidone—HTR7—nerve—amyotrophic lateral sclerosis	0.00424	0.0181	CbGeAlD
Risperidone—Psoriasis—Riluzole—amyotrophic lateral sclerosis	0.00417	0.00583	CcSEcCtD
Risperidone—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.00404	0.00565	CcSEcCtD
Risperidone—DRD2—nerve—amyotrophic lateral sclerosis	0.00401	0.0171	CbGeAlD
Risperidone—Upset stomach—Riluzole—amyotrophic lateral sclerosis	0.004	0.00559	CcSEcCtD
Risperidone—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00399	0.017	CbGeAlD
Risperidone—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00388	0.00543	CcSEcCtD
Risperidone—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.00384	0.00537	CcSEcCtD
Risperidone—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00384	0.00537	CcSEcCtD
Risperidone—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.00384	0.00537	CcSEcCtD
Risperidone—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.00381	0.00532	CcSEcCtD
Risperidone—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.00381	0.00532	CcSEcCtD
Risperidone—Haemoglobin decreased—Riluzole—amyotrophic lateral sclerosis	0.00381	0.00532	CcSEcCtD
Risperidone—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.00377	0.00527	CcSEcCtD
Risperidone—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00374	0.00522	CcSEcCtD
Risperidone—HTR2A—appendage—amyotrophic lateral sclerosis	0.00373	0.0159	CbGeAlD
Risperidone—Delusion—Riluzole—amyotrophic lateral sclerosis	0.0037	0.00518	CcSEcCtD
Risperidone—Ileus—Riluzole—amyotrophic lateral sclerosis	0.0037	0.00518	CcSEcCtD
Risperidone—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00367	0.00513	CcSEcCtD
Risperidone—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.00367	0.00513	CcSEcCtD
Risperidone—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00364	0.00508	CcSEcCtD
Risperidone—Mania—Riluzole—amyotrophic lateral sclerosis	0.0036	0.00504	CcSEcCtD
Risperidone—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.00354	0.00495	CcSEcCtD
Risperidone—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00351	0.00491	CcSEcCtD
Risperidone—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.00348	0.00487	CcSEcCtD
Risperidone—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00348	0.00487	CcSEcCtD
Risperidone—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00478	CcSEcCtD
Risperidone—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00339	0.0145	CbGeAlD
Risperidone—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.00337	0.00471	CcSEcCtD
Risperidone—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.00332	0.0142	CbGeAlD
Risperidone—Abscess—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00463	CcSEcCtD
Risperidone—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00326	0.00456	CcSEcCtD
Risperidone—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.00323	0.00452	CcSEcCtD
Risperidone—H1F0—embryo—amyotrophic lateral sclerosis	0.00322	0.0137	CbGeAlD
Risperidone—Gamma-glutamyltransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00319	0.00445	CcSEcCtD
Risperidone—HTR7—hindbrain—amyotrophic lateral sclerosis	0.00317	0.0135	CbGeAlD
Risperidone—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00442	CcSEcCtD
Risperidone—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.00311	0.00435	CcSEcCtD
Risperidone—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.00309	0.00432	CcSEcCtD
Risperidone—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.00306	0.0131	CbGeAlD
Risperidone—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00305	0.00426	CcSEcCtD
Risperidone—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.003	0.0042	CcSEcCtD
Risperidone—DRD2—hindbrain—amyotrophic lateral sclerosis	0.003	0.0128	CbGeAlD
Risperidone—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00298	0.00417	CcSEcCtD
Risperidone—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00408	CcSEcCtD
Risperidone—DRD1—brainstem—amyotrophic lateral sclerosis	0.00291	0.0124	CbGeAlD
Risperidone—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.0029	0.00406	CcSEcCtD
Risperidone—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.0029	0.00406	CcSEcCtD
Risperidone—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00403	CcSEcCtD
Risperidone—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00403	CcSEcCtD
Risperidone—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00286	0.004	CcSEcCtD
Risperidone—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00279	0.0039	CcSEcCtD
Risperidone—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00277	0.00387	CcSEcCtD
Risperidone—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00277	0.00387	CcSEcCtD
Risperidone—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00277	0.00387	CcSEcCtD
Risperidone—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00375	CcSEcCtD
Risperidone—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00373	CcSEcCtD
Risperidone—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00265	0.00371	CcSEcCtD
Risperidone—HTR2A—nerve—amyotrophic lateral sclerosis	0.00264	0.0113	CbGeAlD
Risperidone—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00366	CcSEcCtD
Risperidone—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00366	CcSEcCtD
Risperidone—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00366	CcSEcCtD
Risperidone—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.00261	0.00364	CcSEcCtD
Risperidone—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00256	0.00358	CcSEcCtD
Risperidone—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00354	CcSEcCtD
Risperidone—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00354	CcSEcCtD
Risperidone—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00249	0.00348	CcSEcCtD
Risperidone—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00246	0.00344	CcSEcCtD
Risperidone—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00337	CcSEcCtD
Risperidone—Coma—Riluzole—amyotrophic lateral sclerosis	0.00239	0.00335	CcSEcCtD
Risperidone—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00237	0.00331	CcSEcCtD
Risperidone—HTR1B—brainstem—amyotrophic lateral sclerosis	0.00236	0.0101	CbGeAlD
Risperidone—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00233	0.00326	CcSEcCtD
Risperidone—DRD4—brain—amyotrophic lateral sclerosis	0.00232	0.00988	CbGeAlD
Risperidone—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.0023	0.00321	CcSEcCtD
Risperidone—HTR1D—brainstem—amyotrophic lateral sclerosis	0.00228	0.00975	CbGeAlD
Risperidone—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00227	0.00318	CcSEcCtD
Risperidone—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00227	0.00318	CcSEcCtD
Risperidone—HTR2C—brainstem—amyotrophic lateral sclerosis	0.00226	0.00965	CbGeAlD
Risperidone—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00225	0.00315	CcSEcCtD
Risperidone—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00223	0.00312	CcSEcCtD
Risperidone—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00223	0.00312	CcSEcCtD
Risperidone—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00309	CcSEcCtD
Risperidone—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00219	0.00306	CcSEcCtD
Risperidone—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00303	CcSEcCtD
Risperidone—DRD3—nervous system—amyotrophic lateral sclerosis	0.00213	0.00909	CbGeAlD
Risperidone—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00297	CcSEcCtD
Risperidone—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00297	CcSEcCtD
Risperidone—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00296	CcSEcCtD
Risperidone—H1F0—medulla oblongata—amyotrophic lateral sclerosis	0.00206	0.00877	CbGeAlD
Risperidone—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00287	CcSEcCtD
Risperidone—DRD3—central nervous system—amyotrophic lateral sclerosis	0.00205	0.00875	CbGeAlD
Risperidone—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00283	CcSEcCtD
Risperidone—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00283	CcSEcCtD
Risperidone—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00281	CcSEcCtD
Risperidone—Thirst—Riluzole—amyotrophic lateral sclerosis	0.002	0.00279	CcSEcCtD
Risperidone—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.00198	0.00845	CbGeAlD
Risperidone—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00276	CcSEcCtD
Risperidone—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00275	CcSEcCtD
Risperidone—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00274	CcSEcCtD
Risperidone—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00267	CcSEcCtD
Risperidone—HTR1A—brainstem—amyotrophic lateral sclerosis	0.0019	0.00812	CbGeAlD
Risperidone—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00266	CcSEcCtD
Risperidone—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00266	CcSEcCtD
Risperidone—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00266	CcSEcCtD
Risperidone—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00189	0.00264	CcSEcCtD
Risperidone—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00262	CcSEcCtD
Risperidone—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00262	CcSEcCtD
Risperidone—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00186	0.0026	CcSEcCtD
Risperidone—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00257	CcSEcCtD
Risperidone—H1F0—spinal cord—amyotrophic lateral sclerosis	0.00183	0.00782	CbGeAlD
Risperidone—HTR7—brainstem—amyotrophic lateral sclerosis	0.00182	0.00776	CbGeAlD
Risperidone—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00181	0.00253	CcSEcCtD
Risperidone—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00181	0.00253	CcSEcCtD
Risperidone—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.0018	0.00769	CbGeAlD
Risperidone—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00252	CcSEcCtD
Risperidone—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00179	0.0025	CcSEcCtD
Risperidone—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00247	CcSEcCtD
Risperidone—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.00175	0.00749	CbGeAlD
Risperidone—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00243	CcSEcCtD
Risperidone—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00242	CcSEcCtD
Risperidone—DRD2—brainstem—amyotrophic lateral sclerosis	0.00172	0.00734	CbGeAlD
Risperidone—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00172	0.0024	CcSEcCtD
Risperidone—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00239	CcSEcCtD
Risperidone—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00235	CcSEcCtD
Risperidone—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00235	CcSEcCtD
Risperidone—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00235	CcSEcCtD
Risperidone—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00231	CcSEcCtD
Risperidone—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00164	0.0023	CcSEcCtD
Risperidone—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00164	0.0023	CcSEcCtD
Risperidone—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00164	0.0023	CcSEcCtD
Risperidone—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.00164	0.00698	CbGeAlD
Risperidone—DRD3—brain—amyotrophic lateral sclerosis	0.00163	0.00695	CbGeAlD
Risperidone—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00225	CcSEcCtD
Risperidone—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00224	CcSEcCtD
Risperidone—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00221	CcSEcCtD
Risperidone—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.00158	0.00673	CbGeAlD
Risperidone—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00158	0.0022	CcSEcCtD
Risperidone—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.00158	0.00672	CbGeAlD
Risperidone—H1F0—nervous system—amyotrophic lateral sclerosis	0.00154	0.00659	CbGeAlD
Risperidone—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00215	CcSEcCtD
Risperidone—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00215	CcSEcCtD
Risperidone—DRD1—nervous system—amyotrophic lateral sclerosis	0.00153	0.00651	CbGeAlD
Risperidone—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00212	CcSEcCtD
Risperidone—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00212	CcSEcCtD
Risperidone—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.0015	0.0021	CcSEcCtD
Risperidone—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00209	CcSEcCtD
Risperidone—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00208	CcSEcCtD
Risperidone—H1F0—central nervous system—amyotrophic lateral sclerosis	0.00149	0.00635	CbGeAlD
Risperidone—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00206	CcSEcCtD
Risperidone—DRD1—central nervous system—amyotrophic lateral sclerosis	0.00147	0.00627	CbGeAlD
Risperidone—HTR1B—spinal cord—amyotrophic lateral sclerosis	0.00147	0.00626	CbGeAlD
Risperidone—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00205	CcSEcCtD
Risperidone—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00205	CcSEcCtD
Risperidone—Depression—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00204	CcSEcCtD
Risperidone—H1F0—cerebellum—amyotrophic lateral sclerosis	0.00145	0.0062	CbGeAlD
Risperidone—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00202	CcSEcCtD
Risperidone—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00201	CcSEcCtD
Risperidone—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00201	CcSEcCtD
Risperidone—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00143	0.002	CcSEcCtD
Risperidone—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00143	0.002	CcSEcCtD
Risperidone—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00199	CcSEcCtD
Risperidone—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.00141	0.006	CbGeAlD
Risperidone—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00196	CcSEcCtD
Risperidone—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00195	CcSEcCtD
Risperidone—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00194	CcSEcCtD
Risperidone—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00193	CcSEcCtD
Risperidone—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00192	CcSEcCtD
Risperidone—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00191	CcSEcCtD
Risperidone—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00187	CcSEcCtD
Risperidone—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00185	CcSEcCtD
Risperidone—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00184	CcSEcCtD
Risperidone—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00184	CcSEcCtD
Risperidone—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00184	CcSEcCtD
Risperidone—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00183	CcSEcCtD
Risperidone—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00183	CcSEcCtD
Risperidone—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00182	CcSEcCtD
Risperidone—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00181	CcSEcCtD
Risperidone—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00181	CcSEcCtD
Risperidone—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00129	0.0018	CcSEcCtD
Risperidone—HTR7—medulla oblongata—amyotrophic lateral sclerosis	0.00127	0.00541	CbGeAlD
Risperidone—ADRA1B—brain—amyotrophic lateral sclerosis	0.00125	0.00534	CbGeAlD
Risperidone—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00174	CcSEcCtD
Risperidone—HTR2A—embryo—amyotrophic lateral sclerosis	0.00124	0.00528	CbGeAlD
Risperidone—HTR1B—nervous system—amyotrophic lateral sclerosis	0.00124	0.00527	CbGeAlD
Risperidone—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00172	CcSEcCtD
Risperidone—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00171	CcSEcCtD
Risperidone—HTR1D—nervous system—amyotrophic lateral sclerosis	0.0012	0.00511	CbGeAlD
Risperidone—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00167	CcSEcCtD
Risperidone—HTR1B—central nervous system—amyotrophic lateral sclerosis	0.00119	0.00508	CbGeAlD
Risperidone—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00166	CcSEcCtD
Risperidone—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00166	CcSEcCtD
Risperidone—HTR2C—nervous system—amyotrophic lateral sclerosis	0.00119	0.00506	CbGeAlD
Risperidone—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.00118	0.00505	CbGeAlD
Risperidone—KCNH2—medulla oblongata—amyotrophic lateral sclerosis	0.00118	0.00504	CbGeAlD
Risperidone—Chills—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00165	CcSEcCtD
Risperidone—H1F0—brain—amyotrophic lateral sclerosis	0.00118	0.00504	CbGeAlD
Risperidone—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00164	CcSEcCtD
Risperidone—ADRA2C—medulla oblongata—amyotrophic lateral sclerosis	0.00117	0.00498	CbGeAlD
Risperidone—DRD1—brain—amyotrophic lateral sclerosis	0.00117	0.00498	CbGeAlD
Risperidone—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00163	CcSEcCtD
Risperidone—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00161	CcSEcCtD
Risperidone—HTR1D—central nervous system—amyotrophic lateral sclerosis	0.00115	0.00492	CbGeAlD
Risperidone—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00115	0.0016	CcSEcCtD
Risperidone—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.00114	0.00487	CbGeAlD
Risperidone—HTR2A—brainstem—amyotrophic lateral sclerosis	0.00113	0.00484	CbGeAlD
Risperidone—HTR7—spinal cord—amyotrophic lateral sclerosis	0.00113	0.00483	CbGeAlD
Risperidone—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00158	CcSEcCtD
Risperidone—Tension—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00157	CcSEcCtD
Risperidone—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00157	CcSEcCtD
Risperidone—HTR2B—nervous system—amyotrophic lateral sclerosis	0.00111	0.00475	CbGeAlD
Risperidone—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00156	CcSEcCtD
Risperidone—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00155	CcSEcCtD
Risperidone—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00154	CcSEcCtD
Risperidone—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00107	0.0015	CcSEcCtD
Risperidone—HTR2B—central nervous system—amyotrophic lateral sclerosis	0.00107	0.00457	CbGeAlD
Risperidone—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00149	CcSEcCtD
Risperidone—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00148	CcSEcCtD
Risperidone—KCNH2—spinal cord—amyotrophic lateral sclerosis	0.00105	0.0045	CbGeAlD
Risperidone—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00147	CcSEcCtD
Risperidone—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00146	CcSEcCtD
Risperidone—ADRA2C—spinal cord—amyotrophic lateral sclerosis	0.00104	0.00444	CbGeAlD
Risperidone—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00103	0.00441	CbGeAlD
Risperidone—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00144	CcSEcCtD
Risperidone—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00144	CcSEcCtD
Risperidone—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00144	CcSEcCtD
Risperidone—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00143	CcSEcCtD
Risperidone—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00142	CcSEcCtD
Risperidone—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00141	CcSEcCtD
Risperidone—Cough—Riluzole—amyotrophic lateral sclerosis	0.001	0.0014	CcSEcCtD
Risperidone—HTR1A—nervous system—amyotrophic lateral sclerosis	0.000997	0.00426	CbGeAlD
Risperidone—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000993	0.00139	CcSEcCtD
Risperidone—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000989	0.00138	CcSEcCtD
Risperidone—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000975	0.00136	CcSEcCtD
Risperidone—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000975	0.00136	CcSEcCtD
Risperidone—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000975	0.00136	CcSEcCtD
Risperidone—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000972	0.00136	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000969	0.00135	CcSEcCtD
Risperidone—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000964	0.00135	CcSEcCtD
Risperidone—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.00096	0.0041	CbGeAlD
Risperidone—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000954	0.00133	CcSEcCtD
Risperidone—HTR7—nervous system—amyotrophic lateral sclerosis	0.000953	0.00407	CbGeAlD
Risperidone—HTR1B—brain—amyotrophic lateral sclerosis	0.000945	0.00403	CbGeAlD
Risperidone—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000943	0.00132	CcSEcCtD
Risperidone—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.000939	0.004	CbGeAlD
Risperidone—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000935	0.00131	CcSEcCtD
Risperidone—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000935	0.00131	CcSEcCtD
Risperidone—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00093	0.00397	CbGeAlD
Risperidone—Infection—Riluzole—amyotrophic lateral sclerosis	0.000929	0.0013	CcSEcCtD
Risperidone—Shock—Riluzole—amyotrophic lateral sclerosis	0.00092	0.00129	CcSEcCtD
Risperidone—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.000919	0.00392	CbGeAlD
Risperidone—HTR7—central nervous system—amyotrophic lateral sclerosis	0.000918	0.00392	CbGeAlD
Risperidone—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000917	0.00128	CcSEcCtD
Risperidone—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000915	0.00128	CcSEcCtD
Risperidone—HTR1D—brain—amyotrophic lateral sclerosis	0.000915	0.0039	CbGeAlD
Risperidone—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000913	0.00128	CcSEcCtD
Risperidone—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000908	0.00127	CcSEcCtD
Risperidone—HTR2C—brain—amyotrophic lateral sclerosis	0.000906	0.00386	CbGeAlD
Risperidone—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000904	0.00126	CcSEcCtD
Risperidone—DRD2—nervous system—amyotrophic lateral sclerosis	0.000901	0.00385	CbGeAlD
Risperidone—HTR7—cerebellum—amyotrophic lateral sclerosis	0.000897	0.00383	CbGeAlD
Risperidone—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000891	0.00125	CcSEcCtD
Risperidone—KCNH2—nervous system—amyotrophic lateral sclerosis	0.000888	0.00379	CbGeAlD
Risperidone—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.000885	0.00378	CbGeAlD
Risperidone—ADRA2C—nervous system—amyotrophic lateral sclerosis	0.000876	0.00374	CbGeAlD
Risperidone—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000874	0.00122	CcSEcCtD
Risperidone—DRD2—central nervous system—amyotrophic lateral sclerosis	0.000868	0.0037	CbGeAlD
Risperidone—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.000865	0.00369	CbGeAlD
Risperidone—KCNH2—central nervous system—amyotrophic lateral sclerosis	0.000855	0.00365	CbGeAlD
Risperidone—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000852	0.00119	CcSEcCtD
Risperidone—HTR2B—brain—amyotrophic lateral sclerosis	0.000851	0.00363	CbGeAlD
Risperidone—DRD2—cerebellum—amyotrophic lateral sclerosis	0.000848	0.00362	CbGeAlD
Risperidone—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000846	0.00118	CcSEcCtD
Risperidone—ADRA2C—central nervous system—amyotrophic lateral sclerosis	0.000844	0.0036	CbGeAlD
Risperidone—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00084	0.00117	CcSEcCtD
Risperidone—KCNH2—cerebellum—amyotrophic lateral sclerosis	0.000836	0.00357	CbGeAlD
Risperidone—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000834	0.00117	CcSEcCtD
Risperidone—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000831	0.00116	CcSEcCtD
Risperidone—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.00083	0.00354	CbGeAlD
Risperidone—ADRA2C—cerebellum—amyotrophic lateral sclerosis	0.000824	0.00352	CbGeAlD
Risperidone—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000823	0.00115	CcSEcCtD
Risperidone—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000813	0.00114	CcSEcCtD
Risperidone—ABCB1—embryo—amyotrophic lateral sclerosis	0.000811	0.00346	CbGeAlD
Risperidone—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000807	0.00113	CcSEcCtD
Risperidone—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000806	0.00113	CcSEcCtD
Risperidone—Pain—Riluzole—amyotrophic lateral sclerosis	0.0008	0.00112	CcSEcCtD
Risperidone—Constipation—Riluzole—amyotrophic lateral sclerosis	0.0008	0.00112	CcSEcCtD
Risperidone—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.000791	0.00338	CbGeAlD
Risperidone—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00077	0.00108	CcSEcCtD
Risperidone—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000765	0.00107	CcSEcCtD
Risperidone—HTR1A—brain—amyotrophic lateral sclerosis	0.000762	0.00325	CbGeAlD
Risperidone—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000743	0.00104	CcSEcCtD
Risperidone—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000739	0.00103	CcSEcCtD
Risperidone—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000739	0.00103	CcSEcCtD
Risperidone—HTR7—brain—amyotrophic lateral sclerosis	0.000729	0.00311	CbGeAlD
Risperidone—HRH1—nervous system—amyotrophic lateral sclerosis	0.000712	0.00304	CbGeAlD
Risperidone—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.000705	0.00301	CbGeAlD
Risperidone—ADRA1A—brain—amyotrophic lateral sclerosis	0.000703	0.003	CbGeAlD
Risperidone—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.000699	0.00298	CbGeAlD
Risperidone—DRD2—brain—amyotrophic lateral sclerosis	0.000689	0.00294	CbGeAlD
Risperidone—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000689	0.000963	CcSEcCtD
Risperidone—HRH1—central nervous system—amyotrophic lateral sclerosis	0.000685	0.00292	CbGeAlD
Risperidone—KCNH2—brain—amyotrophic lateral sclerosis	0.000679	0.0029	CbGeAlD
Risperidone—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.000673	0.00287	CbGeAlD
Risperidone—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000671	0.000938	CcSEcCtD
Risperidone—ADRA2C—brain—amyotrophic lateral sclerosis	0.00067	0.00286	CbGeAlD
Risperidone—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000662	0.000925	CcSEcCtD
Risperidone—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.000658	0.00281	CbGeAlD
Risperidone—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00064	0.000894	CcSEcCtD
Risperidone—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000618	0.000864	CcSEcCtD
Risperidone—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000594	0.000831	CcSEcCtD
Risperidone—HTR2A—nervous system—amyotrophic lateral sclerosis	0.000594	0.00254	CbGeAlD
Risperidone—Rash—Riluzole—amyotrophic lateral sclerosis	0.00059	0.000824	CcSEcCtD
Risperidone—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000589	0.000823	CcSEcCtD
Risperidone—Headache—Riluzole—amyotrophic lateral sclerosis	0.000586	0.000819	CcSEcCtD
Risperidone—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.000572	0.00244	CbGeAlD
Risperidone—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.000559	0.00239	CbGeAlD
Risperidone—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000555	0.000776	CcSEcCtD
Risperidone—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00055	0.00235	CbGeAlD
Risperidone—HRH1—brain—amyotrophic lateral sclerosis	0.000544	0.00232	CbGeAlD
Risperidone—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000542	0.00231	CbGeAlD
Risperidone—ADRA2A—brain—amyotrophic lateral sclerosis	0.000534	0.00228	CbGeAlD
Risperidone—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00053	0.00226	CbGeAlD
Risperidone—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000521	0.00222	CbGeAlD
Risperidone—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000518	0.00221	CbGeAlD
Risperidone—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.00051	0.00217	CbGeAlD
Risperidone—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000462	0.00197	CbGeAlD
Risperidone—HTR2A—brain—amyotrophic lateral sclerosis	0.000454	0.00194	CbGeAlD
Risperidone—CYP2D6—brain—amyotrophic lateral sclerosis	0.000414	0.00177	CbGeAlD
Risperidone—ABCB1—nervous system—amyotrophic lateral sclerosis	0.00039	0.00166	CbGeAlD
Risperidone—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000375	0.0016	CbGeAlD
Risperidone—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000367	0.00156	CbGeAlD
Risperidone—ABCB1—brain—amyotrophic lateral sclerosis	0.000298	0.00127	CbGeAlD
Risperidone—ADRA2B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.66e-05	0.000427	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.64e-05	0.000422	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.63e-05	0.000418	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	1.62e-05	0.000416	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.6e-05	0.000412	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.6e-05	0.000412	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.59e-05	0.00041	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.59e-05	0.000409	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.57e-05	0.000403	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.56e-05	0.000402	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.55e-05	0.000399	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.55e-05	0.000398	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.55e-05	0.000398	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.54e-05	0.000397	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.54e-05	0.000395	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.53e-05	0.000394	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.53e-05	0.000393	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.53e-05	0.000393	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.53e-05	0.000392	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.52e-05	0.000392	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.52e-05	0.000391	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.51e-05	0.000389	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.5e-05	0.000384	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.49e-05	0.000384	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.49e-05	0.000383	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.48e-05	0.000381	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.47e-05	0.000378	CbGpPWpGaD
Risperidone—ADRA2B—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.45e-05	0.000374	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.45e-05	0.000372	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.45e-05	0.000372	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.44e-05	0.000371	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.44e-05	0.000369	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.43e-05	0.000366	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.42e-05	0.000365	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.41e-05	0.000362	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.41e-05	0.000362	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.41e-05	0.000361	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.4e-05	0.000361	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.4e-05	0.000359	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.39e-05	0.000357	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.39e-05	0.000357	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.39e-05	0.000356	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.38e-05	0.000356	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.38e-05	0.000356	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.38e-05	0.000355	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.38e-05	0.000354	CbGpPWpGaD
Risperidone—ADRA2C—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.36e-05	0.000349	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.36e-05	0.000348	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.35e-05	0.000348	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.35e-05	0.000347	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.33e-05	0.000342	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.33e-05	0.000342	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.33e-05	0.000341	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.32e-05	0.000341	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.32e-05	0.00034	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.32e-05	0.00034	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.31e-05	0.000336	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.31e-05	0.000336	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.29e-05	0.000331	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.29e-05	0.000331	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.28e-05	0.00033	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.28e-05	0.000328	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.28e-05	0.000328	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.27e-05	0.000326	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.27e-05	0.000326	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.26e-05	0.000324	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.26e-05	0.000324	CbGpPWpGaD
Risperidone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.26e-05	0.000323	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.25e-05	0.00032	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.24e-05	0.000319	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.24e-05	0.000319	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.23e-05	0.000316	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.23e-05	0.000315	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.22e-05	0.000314	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.21e-05	0.00031	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.2e-05	0.00031	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.19e-05	0.000306	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.18e-05	0.000304	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.18e-05	0.000304	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.18e-05	0.000303	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.17e-05	0.000301	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.17e-05	0.0003	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.17e-05	0.0003	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.16e-05	0.000297	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.15e-05	0.000296	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.15e-05	0.000295	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.15e-05	0.000295	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.14e-05	0.000293	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.14e-05	0.000293	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.13e-05	0.000291	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.13e-05	0.000289	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.11e-05	0.000285	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.1e-05	0.000283	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.1e-05	0.000283	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.1e-05	0.000283	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.1e-05	0.000282	CbGpPWpGaD
Risperidone—ADRA2B—Hemostasis—TP53—amyotrophic lateral sclerosis	1.1e-05	0.000282	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.1e-05	0.000282	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.09e-05	0.000279	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.09e-05	0.000279	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.08e-05	0.000279	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.07e-05	0.000275	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.07e-05	0.000274	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.06e-05	0.000272	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	1.05e-05	0.00027	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.05e-05	0.000269	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.04e-05	0.000266	CbGpPWpGaD
Risperidone—ADRA2C—Hemostasis—TP53—amyotrophic lateral sclerosis	1.03e-05	0.000264	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.02e-05	0.000263	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.02e-05	0.000262	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—APOE—amyotrophic lateral sclerosis	1.02e-05	0.000262	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.01e-05	0.00026	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.01e-05	0.000259	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	1e-05	0.000258	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1e-05	0.000257	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.84e-06	0.000253	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.83e-06	0.000253	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.82e-06	0.000252	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.81e-06	0.000252	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.76e-06	0.000251	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.64e-06	0.000248	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.56e-06	0.000246	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.47e-06	0.000243	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.42e-06	0.000242	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.41e-06	0.000242	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.4e-06	0.000242	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.25e-06	0.000238	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.23e-06	0.000237	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.23e-06	0.000237	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.16e-06	0.000235	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.13e-06	0.000235	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.06e-06	0.000233	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.01e-06	0.000232	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.98e-06	0.000231	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.95e-06	0.00023	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.81e-06	0.000227	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.77e-06	0.000225	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	8.68e-06	0.000223	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.53e-06	0.000219	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.47e-06	0.000218	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.42e-06	0.000216	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.39e-06	0.000216	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.36e-06	0.000215	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	8.33e-06	0.000214	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.31e-06	0.000214	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	8.28e-06	0.000213	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.18e-06	0.00021	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.16e-06	0.00021	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.01e-06	0.000206	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.74e-06	0.000199	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.61e-06	0.000196	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.6e-06	0.000195	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	7.59e-06	0.000195	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.58e-06	0.000195	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.56e-06	0.000194	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.54e-06	0.000194	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.51e-06	0.000193	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.45e-06	0.000192	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.44e-06	0.000191	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.36e-06	0.000189	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.28e-06	0.000187	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.24e-06	0.000186	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.24e-06	0.000186	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.2e-06	0.000185	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.15e-06	0.000184	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.14e-06	0.000184	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.1e-06	0.000183	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.05e-06	0.000181	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.99e-06	0.00018	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.96e-06	0.000179	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.95e-06	0.000179	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.94e-06	0.000178	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.93e-06	0.000178	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.91e-06	0.000178	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.84e-06	0.000176	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.56e-06	0.000169	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.53e-06	0.000168	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.52e-06	0.000168	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.43e-06	0.000165	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.42e-06	0.000165	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.39e-06	0.000164	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.38e-06	0.000164	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.29e-06	0.000162	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.28e-06	0.000161	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.24e-06	0.00016	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.16e-06	0.000158	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.16e-06	0.000158	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.14e-06	0.000158	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.08e-06	0.000156	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.87e-06	0.000151	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.81e-06	0.000149	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	5.73e-06	0.000147	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.72e-06	0.000147	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.68e-06	0.000146	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.61e-06	0.000144	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.58e-06	0.000143	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.53e-06	0.000142	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.49e-06	0.000141	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.46e-06	0.00014	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.42e-06	0.000139	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	5.4e-06	0.000139	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.34e-06	0.000137	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.3e-06	0.000136	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.27e-06	0.000135	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.2e-06	0.000134	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.13e-06	0.000132	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.04e-06	0.00013	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.93e-06	0.000127	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.92e-06	0.000127	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.85e-06	0.000125	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.84e-06	0.000124	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.83e-06	0.000124	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.82e-06	0.000124	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.76e-06	0.000122	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.74e-06	0.000122	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.73e-06	0.000122	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.72e-06	0.000121	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.67e-06	0.00012	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.65e-06	0.00012	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.64e-06	0.000119	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.6e-06	0.000118	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.58e-06	0.000118	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.57e-06	0.000117	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.53e-06	0.000116	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.48e-06	0.000115	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.43e-06	0.000114	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.41e-06	0.000113	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.29e-06	0.00011	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.18e-06	0.000107	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.18e-06	0.000107	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.16e-06	0.000107	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.12e-06	0.000106	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.11e-06	0.000106	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.1e-06	0.000105	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.02e-06	0.000103	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.92e-06	0.000101	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.74e-06	9.61e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.72e-06	9.57e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.7e-06	9.51e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.59e-06	9.24e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.58e-06	9.19e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	3.53e-06	9.07e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.48e-06	8.94e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.42e-06	8.8e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.16e-06	8.11e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.1e-06	7.98e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.1e-06	7.96e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.04e-06	7.81e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.82e-06	7.26e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.42e-06	6.22e-05	CbGpPWpGaD
